Fractional Flow Reserve MarketSize and Trends

Global Fractional Flow Reserve Market Drivers

Leading manufacturers are indulged in the manufacture products for the management of coronary heart disease (CHD). For instance, Phillips launched Instant Wave Free Ratio (iFR) in May 2019, which is the modified version of the currently available FFR in the market. This modified version does not require adenosine which is usually used in FFR for inducing hyperemia in the patients.

Moreover, Heartflow launched a FFR embedded new cardiac CT scanner (FFR_CT) in 2014, which allowed patients to skip the invasive testing procedure carried out during cardiac catheterization process. Furthermore, Opsens, Inc. introduced a guide wire with optic sensing technology called “Optowire” in November 2019. In addition, CathWorks, a company based in Japan, received regulatory approval from U.S. FDA for FFRangio, a non-invasive FFR technique in December 2018.

According to the Centers for Disease Control and Prevention (CDC), 2019, coronary heart disease (CHD) resulted in the death of 365, 914 people world-wide in the year 2017. Moreover, according to the same source, world-wide 18.2 million adults over the age of 20 are suffering from CHD, and 2 in 10 deaths occur in people less than 65 years of age. Development of CHD can be attributed to unhealthy lifestyle such as consumption of food with high sodium levels and fat, decrease in physical activity, smoking, alcohol consumption, and others.

For instance, according to the Heart Disease and Stroke Statistics of AHA report, 2016, around15.5 million people in the U.S. had CHD in the year 2016. According to the same source, around 37.5% men and 18.3% women are suffering from CHD. These factors are expected to drive the global fractional flow reserve market growth over the forecast period.